Wet Time for a Foam Hand Sanitizer
NCT05740332 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2024-09-04
Summary
Hand sanitizers are a standard of hygiene requirements. They must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. Spectrum™ Advanced Hand Sanitizer Foam (70%) (hereby referred to as Spectrum Advanced Foam) kills over 99.99% of germs within 15 seconds while boasting double digit increases in hand moisture after two weeks of use.
In 2002 and 2009 the Center for Disease Control and Prevention (CDC) and World Health Organization (WHO) published guidance that hands should remain wet for at least 15 seconds while being rubbed together after application of an alcohol-based hand rub, though the recommendations do not specify the volume of product to be apply.
This study will evaluate the "wet time" of Spectrum Advanced Foam, which will be defined as the length of time in which the sanitizer foam stays wet on the hands while the participant rubs their hands with the foam sanitizer. The participant will first be asked to wash and dry their hands. Participants will review the appropriate hand sanitizer application steps, as detailed by the WHO guidance. Then, a 1.0 milliliter (mL) aliquot of Spectrum Advanced Foam will be dispensed from an automated dispenser to the participant's hands. The participant will be asked to rub their hands together following the WHO method for hand sanitizer application until they declare the product has dried sufficiently for the donning of medical gloves. Study personnel will measure the wet time of Spectrum Advanced foam using a stopwatch. If the 1.0 ml aliquot does not yield sufficient results to meet WHO guidelines then a 1.4 ml aliquot will be tested, however this was not the case for our study.
Conditions
- Hand Hygiene Effectiveness
Interventions
- DRUG
-
Alcohol hand sanitizer foam
1mL of alcohol foam hand sanitizer automatically dispensed into hands, spread over hands and rubbed until dry. Other Name: Medline Spectrum™ Advanced Hand Sanitizer Foam (70%)
Sponsors & Collaborators
-
Medline Industries
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-12
- Primary Completion
- 2023-01-12
- Completion
- 2023-01-12
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
NCT03564132 ·Status: COMPLETED ·Phase: PHASE2
-
Sideritis Supplementation, Oxidative Stress and Health
NCT05729659 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy of RespireAidTM in Patient With Externally Contracted Seasonal Epidemic (外感時疫)
NCT06086093 ·Status: COMPLETED ·Phase: NA
-
Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients
NCT04967755 ·Status: UNKNOWN ·Phase: NA
-
Jing Si Herbal Tea for Long-Coronavirus Disease(COVID) Gut-brain Interaction
NCT05668104 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis
NCT06763367 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
NCT03828188 ·Status: COMPLETED ·Phase: NA
-
Safety Assessment of Over-the-counter Personal Care and Cosmetic Products Ingredients Based on Product Description
NCT06892067 ·Status: COMPLETED
-
Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients
NCT05055427 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection
NCT04664049 ·Status: UNKNOWN
-
Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19
NCT05778318 ·Status: UNKNOWN
-
The Use of Chinese Herbal Medicine and Vitamin C by Hospital Care Workers in HK to Prevent COVID-19
NCT05360004 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Aromatherapy With Thyme Oil on Disease Symptoms, Vital Signs, Hemodynamic Parameters in COVID-19 Patients
NCT05197569 ·Status: COMPLETED ·Phase: NA
-
Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections
NCT01478009 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Dry Eye
NCT03992287 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
NCT05728918 ·Status: COMPLETED ·Phase: NA
-
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
NCT05212298 ·Status: COMPLETED ·Phase: NA
-
ACUTE AND CHRONIC EFFECTS OF A BOTANICAL EXTRACT ON ANXIETY, PERCEIVED STRESS, MOOD AND CORTISOL IN HEALTHY ADULTS
NCT03639831 ·Status: COMPLETED ·Phase: NA
-
Effects of Peppermint Oil in Mild-moderate Hypertension.
NCT05561543 ·Status: COMPLETED ·Phase: NA
-
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
NCT04790240 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Herbal Extract Study
NCT02095301 ·Status: COMPLETED ·Phase: NA
-
A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects
NCT01007656 ·Status: COMPLETED ·Phase: NA
-
Hericium Erinaceus Mycelium and Probiotic of the Grape King Bio on Symptoms of Premenstrual Syndrome
NCT05443477 ·Status: UNKNOWN ·Phase: NA
-
RCT of Modified Qing Fei Pai Du Tang (mQFPD) for COVID-19
NCT04939415 ·Status: COMPLETED ·Phase: PHASE1
-
China Cimicifuga Trial of Climacteric Complaint Control
NCT00622986 ·Status: UNKNOWN ·Phase: PHASE4